$213 Million is the total value of INCOME RESEARCH & MANAGEMENT's 22 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
WESTERN DIGITAL CORP.note 1.500% 2/0 | $21,213,000 | -0.3% | 22,400,000 | 0.0% | 9.96% | +9.1% | ||
ARES CAPITAL CORPnote 4.625% 3/0 | $20,413,000 | -1.7% | 20,000,000 | 0.0% | 9.58% | +7.6% | ||
SOUTHWEST AIRLS COnote 1.250% 5/0 | $18,523,000 | -3.1% | 16,227,000 | 0.0% | 8.70% | +6.1% | ||
BOOKING HOLDINGS INCnote 0.750% 5/0 | $18,279,000 | +0.2% | 15,216,000 | 0.0% | 8.58% | +9.7% | ||
EURONET WORLDWIDE INCnote 0.750% 3/1 | $18,172,000 | -11.1% | 20,220,000 | 0.0% | 8.53% | -2.7% | ||
ILLUMINA INCnote 8/1 | $17,772,000 | +0.5% | 18,609,000 | 0.0% | 8.34% | +10.0% | ||
HOPE BANCORP INCnote 2.000% 5/1 | $15,070,000 | -2.1% | 15,812,000 | 0.0% | 7.08% | +7.2% | ||
AKAMAI TECHNOLOGIES INCnote 0.125% 5/0 | $12,904,000 | -7.2% | 12,701,000 | 0.0% | 6.06% | +1.6% | ||
TEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0 | $9,580,000 | -18.2% | 12,028,000 | 0.0% | 4.50% | -10.5% | ||
SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $7,275,000 | -0.1% | 7,500,000 | 0.0% | 3.42% | +9.4% | ||
PENNYMAC CORPnote 5.500%11/0 | $6,073,000 | -3.3% | 6,500,000 | 0.0% | 2.85% | +5.8% | ||
BLACKSTONE MORTGAGE TRUST INnote 5.500% 3/1 | $5,104,000 | -6.7% | 6,000,000 | 0.0% | 2.40% | +2.1% | ||
WFCPRL | WELLS FARGO CO NEWperp pfd cnv a | $1,666,000 | -3.0% | 1,425 | 0.0% | 0.78% | +6.1% | |
BACPRL | BK OF AMERICA CORP7.25%cnv pfd l | $1,516,000 | -2.6% | 1,292 | 0.0% | 0.71% | +6.7% | |
FORD MTR CO DELnote 3/1 | $1,372,000 | +0.3% | 1,500,000 | 0.0% | 0.64% | +9.7% | ||
BLOCK INCnote 5/0 | $702,000 | -1.4% | 900,000 | 0.0% | 0.33% | +8.2% | ||
STARWOOD PPTY TR INCnote 4.375% 4/0 | $562,000 | -1.9% | 580,000 | 0.0% | 0.26% | +7.3% | ||
BLACKSTONE MORTGAGE TRUST INnote 4.750% 3/1 | $493,000 | -0.6% | 500,000 | 0.0% | 0.23% | +8.5% | ||
HANNON ARMSTRONG SUST INFR Cnote 8/1 | $334,000 | -4.0% | 355,000 | 0.0% | 0.16% | +5.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-10-20
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BK OF AMERICA CORP | 36 | Q2 2023 | 2.1% |
WELLS FARGO CO NEW | 35 | Q2 2023 | 4.0% |
ALZA CORP | 21 | Q2 2018 | 3.9% |
FIDELITY NATIONAL FINANCIAL | 21 | Q2 2018 | 3.8% |
TEVA PHARMACEUTICAL FIN LLC | 21 | Q2 2018 | 5.3% |
DANAHER CORP DEL | 21 | Q2 2018 | 3.8% |
JEFFERIES GROUP INC NEW | 19 | Q4 2017 | 5.5% |
OLD REP INTL CORP | 19 | Q4 2017 | 4.8% |
RPM INTL INC | 19 | Q2 2018 | 4.3% |
NOVELLUS SYS INC | 19 | Q2 2018 | 4.5% |
View INCOME RESEARCH & MANAGEMENT's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR | 2024-01-19 |
13F-HR | 2023-10-24 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-20 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-20 |
13F-HR | 2022-07-21 |
13F-HR/A | 2022-04-22 |
13F-HR | 2022-04-20 |
View INCOME RESEARCH & MANAGEMENT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.